Pagano Rosana L, Mariano Mario, Giorgi Renata
Laboratory of Pathophysiology, Butantan Institute, São Paulo, Brazil.
Mediators Inflamm. 2006;2006(4):36765. doi: 10.1155/MI/2006/36765.
Calcium-binding protein S100A9 (MRP-14) induces antinociceptive effect in an experimental model of painful sensibility and participates of antinociception observed during neutrophilic peritonitis induced by glycogen or carrageenan in mice. In this study, the direct antinociceptive role of the protein S100A9 in neutrophilic cell-free exudates obtained of mice injected with glycogen was investigated. Mice were intraperitoneally injected with a glycogen solution, and after 4, 8, 24, and 48 hours, either the pattern of cell migration of the peritoneal exudate or the nociceptive response of animals was evaluated. The glycogen-induced neutrophilic peritonitis evoked antinociception 4 and 8 hours after inoculation of the irritant. Peritoneal cell-free exudates, collected in different times after the irritant injection, were transferred to naive animals which were submitted to the nociceptive test. The transference of exudates also induced antinociceptive effect, and neutralization of S100A9 activity by anti-S100A9 monoclonal antibody totally reverted this response. This effect was not observed when experiments were made 24 or 48 hours after glycogen injection. These results clearly indicate that S100A9 is secreted during glycogen-induced neutrophilic peritonitis, and that this protein is responsible by antinociception observed in the initial phase of inflammatory reaction. Thus, these data reinforce the hypothesis that the calcium-binding protein S100A9 participates of the endogenous control of inflammatory pain.
钙结合蛋白S100A9(MRP - 14)在疼痛敏感性实验模型中诱导产生抗伤害感受作用,并参与了小鼠糖原或角叉菜胶诱导的嗜中性粒细胞性腹膜炎期间观察到的抗伤害感受过程。在本研究中,研究了蛋白S100A9在注射糖原的小鼠获得的无嗜中性粒细胞渗出物中的直接抗伤害感受作用。给小鼠腹腔注射糖原溶液,在4、8、24和48小时后,评估腹膜渗出物的细胞迁移模式或动物的伤害感受反应。接种刺激物后4小时和8小时,糖原诱导的嗜中性粒细胞性腹膜炎诱发了抗伤害感受作用。在注射刺激物后的不同时间收集的腹膜无细胞渗出物,转移至接受伤害感受测试的未处理动物。渗出物的转移也诱导了抗伤害感受作用,并且抗S100A9单克隆抗体对S100A9活性的中和完全逆转了这种反应。在糖原注射后24小时或48小时进行实验时未观察到这种效应。这些结果清楚地表明,S100A9在糖原诱导的嗜中性粒细胞性腹膜炎期间分泌,并且该蛋白是炎症反应初始阶段观察到的抗伤害感受的原因。因此,这些数据强化了钙结合蛋白S100A9参与炎症性疼痛内源性控制的假说。